Cipro Hc Suspension/ Drops
NDC Package 50090-7631-0
Package Information
Cipro Hc (ciprofloxacin hydrochloride and hydrocortisone) suspension/ dropses is a medication used to treat bacterial ear infections. This formulation utilizes a suspension/ drops delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-7631 and is authorized under FDA application NDA020805.
Identification & Billing
- RxCUI: 213320 - Cipro HC 0.2 % / 1 % Otic Suspension
- RxCUI: 213320 - ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension [Cipro HC]
- RxCUI: 213320 - Cipro HC (ciprofloxacin 0.2 % / hydrocortisone 1 % ) Otic Suspension
- RxCUI: 213320 - Cipro HC 2/10 Otic Suspension
- RxCUI: 309305 - ciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-7631 - Cipro Hc
- 50090-7631-0 - 1 BOTTLE in 1 CARTON / 10 mL in 1 BOTTLE
- 50090-7631 - Cipro Hc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-7631-0 identifies a specific commercial package of 1 bottle in 1 carton / 10 ml in 1 bottle of Cipro Hc, a human prescription drug labeled by A-s Medication Solutions. This suspension/ drops is formulated for auricular (otic) use and contains ciprofloxacin hydrochloride; hydrocortisone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on March 15, 1999. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat bacterial ear infections. It is used to treat outer ear infections (also known as swimmer's ear) in children and adults. This medication contains a combination of ciprofloxacin (a quinolone-type antibiotic) and hydrocortisone (an anti-inflammatory corticosteroid). This ear drop works by stopping the growth of bacteria and reducing ear swelling and discomfort. This medication treats only bacterial ear infections. It will not work for other types of ear infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090763100. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.